Arbutus Biopharma (ABUS) Other Non-Current Liabilities (2011 - 2026)
Arbutus Biopharma's Other Non-Current Liabilities came in at $8.82 million for Q2 2026, down 18.2% from $10.78 million a year earlier but up 2.5% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
At the end of FY2025, Arbutus Biopharma's Other Non-Current Liabilities was $8.4 million, down 17.9% from FY2024.
- Other Non-Current Liabilities carries a five-year compound annual growth rate of -15.6% (FY2020 to FY2025).
- Going back by year, Other Non-Current Liabilities was $10.23 million in FY2024 (+34.5%), $7.6 million in FY2023 (-26.7%), $10.37 million in FY2022 (-36.4%) and $16.3 million in FY2021 (-16.7%).
- The five-year range for quarterly Other Non-Current Liabilities is $7.6 million (Q4 2023) to $17.88 million (Q3 2021).
- Year-over-year, Other Non-Current Liabilities has declined for three consecutive quarters, with growth averaging 10.8% over the last eight quarters.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q1 2025 (growth of 35.3%), and the weakest in Q1 2023 (a decline of 39.2%).
- Business Quant data shows ABUS's Other Non-Current Liabilities at $8.6 million (Q1 2026), $8.4 million (Q4 2025) and $11.1 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn |
| 10 | Arbutus Biopharma | 841.23 Mn | 468.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.93 Mn |
| Mar 31, 2026 | 11.88 Mn |
| Dec 31, 2025 | 11.84 Mn |
| Sep 30, 2025 | 14.78 Mn |
| Jun 30, 2025 | 14.69 Mn |
| Mar 31, 2025 | 14.93 Mn |
| Dec 31, 2024 | 15.05 Mn |
| Sep 30, 2024 | 13.65 Mn |
| Jun 30, 2024 | 13.85 Mn |
| Mar 31, 2024 | 14.18 Mn |
| Dec 31, 2023 | 14.55 Mn |
| Sep 30, 2023 | 15.48 Mn |
| Jun 30, 2023 | 15.96 Mn |
| Mar 31, 2023 | 17.19 Mn |
| Dec 31, 2022 | 17.90 Mn |
| Sep 30, 2022 | 18.24 Mn |
| Jun 30, 2022 | 19.94 Mn |
| Mar 31, 2022 | 19.07 Mn |
| Dec 31, 2021 | 21.59 Mn |
| Sep 30, 2021 | 22.99 Mn |
API Access
Arbutus Biopharma Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();